CB1 receptor mediates the effects of glucocorticoids on AMPK activity in the hypothalamus.

CB1 receptor mediates the effects of glucocorticoids on AMPK activity in the hypothalamus.

AMP-activated protein kinase (AMPK), a regulator of cellular and systemic energy homeostasis, can be influenced by several hormones. Tissue-specific alteration of AMPK activity by glucocorticoids may explain the increase in appetite, the accumulation of lipids in adipose tissues, and the detrimental...

Full description

Bibliographic Details
Main Authors:	Scerif, M, Füzesi, T, Thomas, J, Kola, B, Grossman, AB, Fekete, C, Korbonits, M
Format:	Journal article
Language:	English
Published:	2013

Similar Items

The CB1 receptor mediates the peripheral effects of ghrelin on AMPK activity but not on growth hormone release.
by: Kola, B, et al.
Published: (2013)

Expanding role of AMPK in endocrinology.
by: Kola, B, et al.
Published: (2006)

AMPK Mediates Glucocorticoids Stress-Induced Downregulation of the Glucocorticoid Receptor in Cultured Rat Prefrontal Cortical Astrocytes.
by: Shi-Ying Yuan, et al.
Published: (2016-01-01)

Modifications in basal and stress-induced hypothalamic AMP-activated protein kinase (AMPK) activity in rats chronically treated with an angiotensin II receptor blocker.
by: Marques, M, et al.
Published: (2012)

The role of AMP-activated protein kinase in obesity.
by: Kola, B, et al.
Published: (2008)

AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in Cushing's syndrome.
by: Christ-Crain, M, et al.
Published: (2008)

Huntingtin-Associated Protein 1 in Mouse Hypothalamus Stabilizes Glucocorticoid Receptor in Stress Response
by: Xingxing Chen, et al.
Published: (2020-06-01)

GABAergic and cortical and subcortical glutamatergic axon terminals contain CB1 cannabinoid receptors in the ventromedial nucleus of the hypothalamus.
by: Leire Reguero, et al.
Published: (2011-01-01)

CB1 cannabinoid receptor in SF1-expressing neurons of the ventromedial hypothalamus determines metabolic responses to diet and leptin
by: Pierre Cardinal, et al.
Published: (2014-10-01)

Folate and Cobalamin Deficiencies during Pregnancy Disrupt the Glucocorticoid Response in Hypothalamus through <i>N</i>-Homocysteinilation of the Glucocorticoid Receptor
by: Arnaud Michel, et al.
Published: (2023-06-01)

CB2 receptor agonist JWH133 activates AMPK to inhibit growth of C6 glioma cells
by: Wang Feng, et al.
Published: (2019-07-01)

Differential effects of 5AMP-activated protein kinase (AMPK) activation by metformin and AICAR on glucose uptake and lipolysis in human adipocytes
by: Radimerski, T, et al.
Published: (2007)

AMPK in the Ventromedial Nucleus of the Hypothalamus: A Key Regulator for Thermogenesis
by: Hailan Liu, et al.
Published: (2020-09-01)

Correction: Targeted Inactivation of GPR26 Leads to Hyperphagia and Adiposity by Activating AMPK in the Hypothalamus
Published: (2012-01-01)

Correction: Targeted Inactivation of GPR26 Leads to Hyperphagia and Adiposity by Activating AMPK in the Hypothalamus.
by: Daohong Chen, et al.
Published: (2012-01-01)

A naturally hypersensitive glucocorticoid receptor elicits a compensatory reduction of hypothalamus–pituitary–adrenal axis activity early in ontogeny
by: Eduard Muráni, et al.
Published: (2016-01-01)

Cannabigerol Action at Cannabinoid CB1 and CB2 Receptors and at CB1–CB2 Heteroreceptor Complexes
by: Gemma Navarro, et al.
Published: (2018-06-01)

Insulin-like growth factor-I and- II in combination inhibit the release of growth hormone-releasing hormone from the rat hypothalamus in vitro.
by: Korbonits, M, et al.
Published: (1996)

Cannabinoid CB1 and CB2 Receptor-Mediated Arrestin Translocation: Species, Subtype, and Agonist-Dependence
by: Mikkel Søes Ibsen, et al.
Published: (2019-04-01)

The Role of the Lateral Hypothalamus in Violent Intraspecific Aggression—The Glucocorticoid Deficit Hypothesis
by: József Haller, et al.
Published: (2018-06-01)

The role of AMP-activated protein kinase in the metabolic syndrome
by: Christ-Crain, M, et al.
Published: (2007)

STRIATOPALLIDAL CB1 RECEPTORS MEDIATE AMPHETAMINE-INDUCED SENSITIZATION
by: Yamuna Mariani, et al.
Published: (2023-10-01)

The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system.
by: Kola, B, et al.
Published: (2008)

Ghrelin's role as a major regulator of appetite and its other functions in neuroendocrinology.
by: Lim, C, et al.
Published: (2010)

Cannabinoids Modulate Neuronal Activity and Cancer by CB1 and CB2 Receptor-Independent Mechanisms
by: Ken Soderstrom, et al.
Published: (2017-10-01)

Calcium and calmodulin mediation of growth hormone-releasing hormone release from the rat hypothalamus in vitro.
by: Honegger, J, et al.
Published: (1991)

Ghrelin and cannabinoids require the ghrelin receptor to affect cellular energy metabolism
by: Lim, C, et al.
Published: (2013)

Ghrelin and cannabinoids require the ghrelin receptor to affect cellular energy metabolism.
by: Lim, C, et al.
Published: (2013)

Leptin and glucocorticoid signaling pathways in the hypothalamus of female and male fructose-fed rats
by: Vojnović-Milutinović Danijela, et al.
Published: (2014-01-01)

Positive Allosteric Modulation of CB1 and CB2 Cannabinoid Receptors Enhances the Neuroprotective Activity of a Dual CB1R/CB2R Orthosteric Agonist
by: Beatrice Polini, et al.
Published: (2020-12-01)

CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain.
by: Clayton, N, et al.
Published: (2002)

Opiate receptor subtype regulation of CRF-41 release from rat hypothalamus in vitro.
by: Tsagarakis, S, et al.
Published: (1990)

Glucocorticoids induce osteoporosis mediated by glucocorticoid receptor-dependent and -independent pathways
by: Yu Jiang
Published: (2020-10-01)

The expression level of CB1 and CB2 receptors determines their efficacy at inducing apoptosis in astrocytomas.
by: Eiron Cudaback, et al.
Published: (2010-01-01)

Cannabinoid CB1 receptor activation mediates the opposing effects of amphetamine on impulsive action and impulsive choice.
by: Joost Wiskerke, et al.
Published: (2011-01-01)

The growth hormone secretagogue receptor.
by: Korbonits, M, et al.
Published: (1999)

CB1 and CB2 cannabinoid receptors are implicated in inflammatory hypersensitivity to pain
by: Clayton, N, et al.
Published: (2001)

Shenqi Fuzheng injection alleviates chemotherapy-induced cachexia by restoring glucocorticoid signaling in hypothalamus
by: Entezar Berik, et al.
Published: (2024-03-01)

Effects of the peripheral CB1 receptor antagonist JD5037 in mono— and polytherapy with the AMPK activator metformin in a monocrotaline-induced rat model of pulmonary hypertension
by: Patryk Remiszewski, et al.
Published: (2022-09-01)

The CB1Cannabinoid Receptor in the Brain
by: Allyn C. Howlett
Published: (1998-12-01)